The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Just the change in company name......Working hard to increase shareholder value.....lol....NOT
Dougie,
The interims wont be out for a month poss 2, however. they usually provide a profit warning (not expecting anything else) towards the end of July (last year it was on the 22nd, but the year before it was at the beginning of August.
That said, they have provided Op updates a week or two before. anybody's guess what monkeys are thinking,,,,,probably about bananas....lol
So we could possibly get an op update this week or next, although I doubt they will have much to announce. Of course I have been known to be wrong.... ;-)
Last year it was on Jul 22nd
Looks like they will update when the interims are out in a few weeks. I certainly cannot believe the FDA process has been plain sailing. Exactly 5 years from Phase II starts announcement (July 2018) and still no result. Pretty incredible when one considers there were finally less than 100 subjects to process.
Market cap is now at its lowest ever.... 13.2 mill squid. Certainly an eye opener given what they are supposed to have, The DLI is now in negative territory given how much they paid for it and the market cap at the time which was about 16 to 17 mill squid (before they announced the purchase) and half the shares in play (recent consolidation ignored).
I suspect it’s because there is still no licensing/sales deal In place. Without it, there is no value and not many are willing to take the risk and jump in (To be honest I really don’t understand why no agreement was already in place, even if it was based on the understanding of no approval, no deal, although we still don’t know how close they are to signing one). That said, once a license/sales agreement is in place, I would suspect lift off. Just my two pennyworth for what it’s worth.
Of course its irrelevant, but interesting that anyone would want to buy or sell just 1 share !!!
1 share traded so far today at 0.53 ie 5p......lol. Last of the big spenders. Not reading anything into the 1 share transaction since we have seen them before without any consequence. nevertheless, interesting.
Morning The.Italian.
Interesting that someone was willing to accept 0.25 though when others were accepting 0.59 and 0..6 and 0.62.
As to the SPA, only time will tell. Currently the market doesn't think so, but then again RPG/ERP have lost market/shareholder confidence due to past history on dates and all things money making....lol
And the reason….50k sell at 0.25(63% off The listed 0.66)….WTF……Why would anyone do that unless they were thinking their investment had increased from the pre consolidation price……whoops.
Well, it seems 02945 is no longer working. The 33% drop on 0575 must have been correct, although it’s now back to a modest 4+% drop……lol. Mind you the 33%drop is still showing. ;-)
I opened my browser on 0575 this morning to see a 33+% drop, market cap of 10mill squid. …. :-O…..OUCH…..
However, when I refreshed, the system jumped to 02945 and it was back flat without any showing and drop whatsoever…….. The system must be female….very fickle….lol
Onwards n sidewards
Old people do that. Get up early and forget…..lol
Sometimes to their advantage…..
Seems ERP are now parallel trading with both 0575 and 02945 tickers.
Not that it makes any difference on market cap....lol
bothwell,
i think the reason was because rpg (at the time) had no idea what they were doing. especially after their **** up and amateurism shown regarding can size. since ple were the ones who had obtained the approval for the 20 dose can back in 2013, they had the responsibility of first launch before the sunset date 3 years later in 2016. if you happen to remember. the lock in only happened 3 days before that sunset date (nov 2016) which was because ple had forgotten to agree a can price point with recordati and so had to go with the 20 dose can at the last minute (they could put whatever price they wanted for that as i'm sure it wouldn't impact recordati's own endeavors. i'm sure partly because of this, they were stuck with some small online doctors/pharmacy to make the initial roll out and wanted to leave it all with recordati. there was no way they had the experience or knowhow to take it further and recordati were far too busy sorting out their own list of launches - see below. the result was that the uk was left in the lurch, although i'm sure stocks were changed out for the 12 dose can when they became available, but other than that it was left to its own devices.
recordati's initial responsibility was the e5 followed by a few others as per the nov 2016 announcement...the first batch of fortacin will be on commercial sale, by prescription, in the uk from today. thereafter, regent pacific’s commercial partner recordati s.p.a. is expected to begin sales of fortacin™ in italy, spain, france, germany, portugal (e5), czech republic, slovakia, poland, ireland, romania and greece in 2017.
the uk never even left the starting gate and still hasn't. quite incredible given it was one of the top 3 economies in the eu at the time (portugal and spain were never really players to begin with) so should have been more of a priority, but who knows how the contract was written between rpg/ple and recordati.
the rest is history with the impact of manufacturing problems, which again, rpg should have stepped in years ago to sort out but never did.
lest hope with the otc recordati can pull things together, although at 30k cans/quarter, its going to take a long long time.
if there is anything wrong with the above...tough shti...its all in the past now and depressing to think about......lol
incompetence rules ok........lol
Morning The.Italian,
I've just watched the last 30mins of the FUM Investor seminar, particularly where John Connolly is talking about Boots who he stated are now above the NHS wrt sales.
So If that is indeed the case, why haven't Recordati also approached boots for an agreement. It surely would be an ideal complement with Eroxon.
Prof, yes sorry to see you go after so many years.
Far be it for me to advise but, could it not be prudent to wait till the China submission news (due any week after the end of June)? You could then jump out on a possible spike and be able to buy yourself a puncture repair kit too.... :-)
Or even take a look over at FUM. They seem to have gotten their act together and just received FDA OTC approval for their ED Gel which appears already to be selling well in the UK and Belgium (it has absolutely no side effects). You wont necessarily recoup all your losses, but you could consider jumping in and out and buying a bike with 29"wheels instead of the usual 26". :-)
Anyway, good luck with whatever you decide to do.
I appear to have posted 2 similar posts. They are not showing on my PLE BB with first not even being posted as I performed a refresh, hence the writing of 2. What to write other than LSE still seems to be a bit temperamental.
Yesterday it also dropped early on only to finish in positive territory by close. Maybe the same will happen again today.
1.5mill for both the uk and Belgium (67mill and 11.7mill populations respectively) is quite good for just 2 months. Remember the response to the FDA approval RNS, the sp hardly moved. Whodunnit have guessed.
This is a money maker in the making. With a little time, it will start to gain traction. That said, one would have thought they would have had a US licensee waiting at the gates ready for the off which doesn’t appear to be the case.
Just remember it also dropped 4.5% yesterday too, so although it could be considered as fairly good news, there will always be sellers, particularly after the recent increases. I’m going to make a guess that it will possibly gain later in the day once the %traders have finished. But I have been known to be wrong….lol
Not sure what to make of the FUM RNS. 1.5mill seems Low, however. I expect it’s all from boots sales in the UK, which started only a few months ago which could mean 1.5mill is good going. What do you think?